These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24691445)

  • 1. Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression.
    Rielland M; Cantor DJ; Graveline R; Hajdu C; Mara L; Diaz Bde D; Miller G; David G
    J Clin Invest; 2014 May; 124(5):2125-35. PubMed ID: 24691445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma.
    Ling J; Kang Y; Zhao R; Xia Q; Lee DF; Chang Z; Li J; Peng B; Fleming JB; Wang H; Liu J; Lemischka IR; Hung MC; Chiao PJ
    Cancer Cell; 2012 Jan; 21(1):105-20. PubMed ID: 22264792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of p16 and activation of Kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivo.
    Qiu W; Sahin F; Iacobuzio-Donahue CA; Garcia-Carracedo D; Wang WM; Kuo CY; Chen D; Arking DE; Lowy AM; Hruban RH; Remotti HE; Su GH
    Oncotarget; 2011 Nov; 2(11):862-73. PubMed ID: 22113502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
    Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
    Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis.
    Bermejo-Rodriguez C; Araos Henríquez J; Caligiuri G; Pinto Teles S; Park Y; Evans A; Barrera LN; Neesse A; Grützmann R; Aust D; Rümmele P; Knösel T; Narita M; Narita M; Campbell F; Öhlund D; Pilarsky C; Dow LE; Humbert PO; Biffi G; Tuveson DA; Perez-Mancera PA
    Cancer Res; 2024 Sep; 84(18):2968-2984. PubMed ID: 39037766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MT1-MMP cooperates with Kras(G12D) to promote pancreatic fibrosis through increased TGF-β signaling.
    Krantz SB; Shields MA; Dangi-Garimella S; Cheon EC; Barron MR; Hwang RF; Rao MS; Grippo PJ; Bentrem DJ; Munshi HG
    Mol Cancer Res; 2011 Oct; 9(10):1294-304. PubMed ID: 21856775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer.
    Weng CC; Hsieh MJ; Wu CC; Lin YC; Shan YS; Hung WC; Chen LT; Cheng KH
    Mol Cancer; 2019 May; 18(1):96. PubMed ID: 31109321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer.
    Shimazaki R; Takano S; Satoh M; Takada M; Miyahara Y; Sasaki K; Yoshitomi H; Kagawa S; Furukawa K; Takayashiki T; Kuboki S; Sogawa K; Motohashi S; Nomura F; Miyazaki M; Ohtsuka M
    Cell Oncol (Dordr); 2021 Aug; 44(4):937-950. PubMed ID: 34075561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGIF1 functions as a tumor suppressor in pancreatic ductal adenocarcinoma.
    Parajuli P; Singh P; Wang Z; Li L; Eragamreddi S; Ozkan S; Ferrigno O; Prunier C; Razzaque MS; Xu K; Atfi A
    EMBO J; 2019 Jul; 38(13):e101067. PubMed ID: 31268604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer.
    Humpton TJ; Alagesan B; DeNicola GM; Lu D; Yordanov GN; Leonhardt CS; Yao MA; Alagesan P; Zaatari MN; Park Y; Skepper JN; Macleod KF; Perez-Mancera PA; Murphy MP; Evan GI; Vousden KH; Tuveson DA
    Cancer Discov; 2019 Sep; 9(9):1268-1287. PubMed ID: 31263025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RelA regulates CXCL1/CXCR2-dependent oncogene-induced senescence in murine Kras-driven pancreatic carcinogenesis.
    Lesina M; Wörmann SM; Morton J; Diakopoulos KN; Korneeva O; Wimmer M; Einwächter H; Sperveslage J; Demir IE; Kehl T; Saur D; Sipos B; Heikenwälder M; Steiner JM; Wang TC; Sansom OJ; Schmid RM; Algül H
    J Clin Invest; 2016 Aug; 126(8):2919-32. PubMed ID: 27454298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multilevel Regulation of NF-κB Signaling by NSD2 Suppresses Kras-Driven Pancreatic Tumorigenesis.
    Feng W; Niu N; Lu P; Chen Z; Rao H; Zhang W; Ma C; Liu C; Xu Y; Gao WQ; Xue J; Li L
    Adv Sci (Weinh); 2024 Aug; 11(30):e2309387. PubMed ID: 38889281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic KRas suppresses inflammation-associated senescence of pancreatic ductal cells.
    Lee KE; Bar-Sagi D
    Cancer Cell; 2010 Nov; 18(5):448-58. PubMed ID: 21075310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The KRAS-PDEδ interaction is a therapeutic target.
    Cancer Discov; 2013 Jul; 3(7):OF20. PubMed ID: 23847364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogene-Induced Senescence Limits the Progression of Pancreatic Neoplasia through Production of Activin A.
    Zhao Y; Wu Z; Chanal M; Guillaumond F; Goehrig D; Bachy S; Principe M; Ziverec A; Flaman JM; Collin G; Tomasini R; Pasternack A; Ritvos O; Vasseur S; Bernard D; Hennino A; Bertolino P
    Cancer Res; 2020 Aug; 80(16):3359-3371. PubMed ID: 32554750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic inflammation initiates multiple forms of K-Ras-independent mouse pancreatic cancer in the absence of TP53.
    Swidnicka-Siergiejko AK; Gomez-Chou SB; Cruz-Monserrate Z; Deng D; Liu Y; Huang H; Ji B; Azizian N; Daniluk J; Lu W; Wang H; Maitra A; Logsdon CD
    Oncogene; 2017 Jun; 36(22):3149-3158. PubMed ID: 27991926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-binding epidermal growth factor-like growth factor eliminates constraints on activated Kras to promote rapid onset of pancreatic neoplasia.
    Ray KC; Moss ME; Franklin JL; Weaver CJ; Higginbotham J; Song Y; Revetta FL; Blaine SA; Bridges LR; Guess KE; Coffey RJ; Crawford HC; Washington MK; Means AL
    Oncogene; 2014 Feb; 33(7):823-31. PubMed ID: 23376846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the prohibitin scaffold-CRAF kinase interaction in RAS-ERK-driven pancreatic ductal adenocarcinoma.
    Luan Z; He Y; Alattar M; Chen Z; He F
    Mol Cancer; 2014 Feb; 13():38. PubMed ID: 24568222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice.
    Grippo PJ; Fitchev PS; Bentrem DJ; Melstrom LG; Dangi-Garimella S; Krantz SB; Heiferman MJ; Chung C; Adrian K; Cornwell ML; Flesche JB; Rao SM; Talamonti MS; Munshi HG; Crawford SE
    Gut; 2012 Oct; 61(10):1454-64. PubMed ID: 22234980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.